HA14-1, Bcl-2 inhibitor. BH-3 mimetic.

Be the first to review this product! Submit a review

|

(0 Publication)

MW 409.2 Da. Cell permeable Bcl-2 inhibitor. BH-3 mimetic. Disrupts Bax and Bcl-2 interactions. Apoptotic anticancer agent.

View Alternative Names

1 25 dihydroxyvitamin D3 receptor, 25-dihydroxyvitamin D3 receptor, AHDC, ALDC, ALDH 1, ALDH 11, ALDH class 1, ALDH class 2, ALDH-E1, ALDH-E2, ALDHI, ALDM, ALHDII, Acetaldehyde dehydrogenase 1, Acetaldehyde dehydrogenase 2, Aldehyde dehydrogenase 1, Aldehyde dehydrogenase 1 family member A1, Aldehyde dehydrogenase 1 soluble, Aldehyde dehydrogenase 1A1, Aldehyde dehydrogenase 2 family, Aldehyde dehydrogenase 2 family (mitochondrial), Aldehyde dehydrogenase cytosolic, Aldehyde dehydrogenase liver cytosolic, Aldehyde dehydrogenase mitochondrial, Aldh, Liver mitochondrial ALDH, MGC1806, MGC2318, Member 1, Mitochondrial aldehyde dehydrogenase 2, NR1I1, Nuclear receptor subfamily 1 group I member 1, Nucleus encoded mitochondrial aldehyde dehydrogenase 2, PPP1R163, PUMB 1, Protein phosphatase 1, regulatory subunit 163, RALDH 1, Retinal dehydrogenase 1, Retinaldehyde dehydrogenase 1, VDR_HUMAN, Vitamin D (1,25- dihydroxyvitamin D3) receptor, Vitamin D hormone receptor, Vitamin D nuclear receptor variant 1, Vitamin D receptor, Vitamin D3 receptor